Biological and clinical features in preclinical and (very) early spondyloarthritis

Recruiting

• Conditions: Bechterew; Spondyloarthritis; 10003816; 10023213

• Registration Number: NL-OMON54532
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 500

Inclusion Criteria

- First degree relative of an HLA-B27 positive Ankylosing Spondylitis
(Bechterew) patient
- Age at inclusion 18-40 years

Exclusion Criteria

- Established diagnosis of sponyloarthritis
- Concomitant conditions that impact participation

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Identify and validate biomarkers which can give more insight in the<br /><br>pathofysiology and (early) diagnosis of SpA</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Create a biobank with biological samples and clinical data to find new<br /><br>biomarkers in SpA patients with future techniques.</p><br>